文献速递临床试验与 GCP医学人工智能与信息学

用于在健康成人中处方、鼓励和评估体育锻炼的创新颠覆性技术:探索性研究及非劣效性研究者盲法随机临床试验方案

Innovative and disruptive technologies to prescribe, encourage, and evaluate physical exercise in healthy adults: a protocol of exploratory study followed by a noninferiority, investigator-blinded randomized clinical trial.
PubMed 文献 · Trials · 2023-10-30

本研究旨在开发并验证创新、颠覆性且安全的技术,以确保合适的运动强度、提高身体活动依从性并监测运动前中后的健康生物标志物反应。研究分三阶段:验证心率与步数传感器、将生物反馈与游戏化整合入应用进行结构化训练处方、以及在非受控环境中实施并开展研究者盲法随机对照非劣效性试验。

要点

  • 三阶段研究:传感器验证、游戏化应用整合、非受控环境随机非劣效性试验。
  • 训练方案为6周、每周5天、每次60分钟,包括5分钟热身、50分钟目标心率训练和5分钟冷身。
  • 干预组使用游戏化应用在非受控环境锻炼,对照组仅接受身体活动指南。

核心结论

  • 预期结果包括通过游戏化应用改善运动依从性、更好地维持处方运动强度以及改善健康生物标志物,研究结果将为健康相关决策提供信息。

研究设计与样本

  • 探索性研究 followed by 非劣效性、研究者盲法随机临床试验,分三阶段:传感器验证、游戏化应用整合、非受控环境随机试验。
  • 第一阶段:在改良穿梭步行测试中验证监测心率和步数的生物传感器。
  • 第二阶段:生物传感器与游戏化智能手机应用对接,训练方案为6周、每周5天、每次60分钟:5分钟热身(原地步行)、50分钟在踏步上以目标心率训练、5分钟冷身(原地速度)。
  • 第三阶段:研究者盲法随机临床试验,参与者随机分配至干预组(IG)或对照组(CG)。
  • 干预组在非受控环境中按照第二阶段所述处方方法使用游戏化应用锻炼;对照组仅接受身体活动实践指南。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cardiovascular diseases are a leading cause of mortality worldwide. A significant contributing factor to this mortality is the lack of engagement in preventive activities. Consequently, strategies for enhancing adherence to and duration of physical activity (PA) have become pivotal. This project aims to create and validate innovative, disruptive, and secure technologies that ensure appropriate exercise intensity, bolster adherence to PA, and monitor health biomarker responses pre-, during, and post-physical activity. METHODS: This exploratory study, followed by a noninferiority, investigator-blinded randomized clinical trial, will be divided into three phases: (1) development and validation of a sensor for real-time biofeedback during a functional assessment test; (2) integration of biofeedback and gamification into an app for the structured prescription of physical training within a controlled setting; and (3) implementation of biofeedback and gamification into an app for the prescription and monitoring of physical training in an uncontrolled setting. Phase 1 entails a validation test of a biosensor-monitoring heart rate (HR) and steps-during a modified shuttle walk test. In phase 2, the biosensor interfaces with a gamified smartphone application. The training regimen spans 6 weeks, 5 days weekly, with each session lasting 60 min: a five-min warm-up involving stationary gait, followed by 50 min of training at the target HR on the step and concluding with a five-min cool-down at a stationary pace. After 6 weeks of training, a new functional capacity test is conducted. Phase 3 involves an investigator-blinded, randomized clinical trial to demonstrate noninferiority. Participants are randomly assigned to either the intervention group (IG) or the control group (CG). IG participants practice exercise using the gamified application in an uncontrolled environment according to the prescribed method outlined in phase 2. CG participants receive PA practice guidelines exclusively. DISCUSSION: Anticipated outcomes include improved exercise adherence through the gamified application, better maintenance of prescribed exercise intensity, and enhanced health biomarkers. The results of this study will inform health-related decision-making. TRIAL REGISTRATION: The study protocol received approval from the Ethics Committee of Universidade Federal de Ciências da Saúde de Porto Alegre (54,492,221.80000.5345) and has been registered with the Brazilian Registry of Clinical Trials (ReBEC, RBR-359p69v).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Loro FL, Martins R, de Araújo CLP, et al. Innovative and disruptive technologies to prescribe, encourage, and evaluate physical exercise in healthy adults: a protocol of exploratory study followed by a noninferiority, investigator-blinded randomized clinical trial. Trials. 2023. PMID: 37904188. doi:10.1186/s13063-023-07747-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。